MedCap AB (publ) (STO:MCAP)
Sweden · Delayed Price · Currency is SEK 551.00
+5.00 (0.92%)
Aug 14, 2026, 5:29 PM CET
MedCap AB Income Statement
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 2,255 | 2,108 | 1,807 | 1,587 | 1,124 | 926.3 |
Other Revenue | 1.6 | 1.6 | 0.6 | 1.6 | 0.2 | - |
| 2,257 | 2,110 | 1,807 | 1,589 | 1,124 | 926.3 | |
Revenue Growth | 18.58% | 16.73% | 13.74% | 41.37% | 21.34% | 11.87% |
Cost of Revenue | 916.7 | 871.9 | 749.6 | 660.7 | 446.8 | 357.7 |
Gross Profit | 1,340 | 1,238 | 1,058 | 928.3 | 677.2 | 568.6 |
Selling, General & Admin | 839 | 791.5 | 698.5 | 601.1 | 443.5 | 384.6 |
Other Operating Expenses | 7.6 | 4.2 | 3 | 7.9 | 3.3 | 4.7 |
Operating Expenses | 1,023 | 949 | 816.9 | 712.1 | 528.1 | 464.8 |
Operating Income | 317.2 | 288.7 | 240.8 | 216.2 | 149.1 | 103.8 |
Interest Expense | -48.8 | -31.5 | -18.5 | -15.6 | -16.4 | -9.4 |
Interest & Investment Income | 4.7 | 5.1 | 8.3 | 7 | 2.3 | 0.4 |
Earnings From Equity Investments | - | - | - | - | - | 1.3 |
Currency Exchange Gain (Loss) | 17.4 | 17.4 | 5 | 14.7 | 2.8 | 1.7 |
Other Non Operating Income (Expenses) | 13.9 | -0.1 | 0.2 | 0.1 | 0.1 | - |
EBT Excluding Unusual Items | 304.4 | 279.6 | 235.8 | 222.4 | 137.9 | 97.8 |
Gain (Loss) on Sale of Assets | - | - | - | - | 20 | 4 |
Asset Writedown | - | - | - | -0.9 | -6.5 | - |
Other Unusual Items | 9.4 | 9.4 | 25.7 | - | 0.6 | 15.1 |
Pretax Income | 313.8 | 289 | 261.6 | 222.3 | 152 | 117 |
Income Tax Expense | 72.5 | 68.3 | 52.3 | 49.8 | 34 | 18.9 |
Earnings From Continuing Operations | 241.3 | 220.7 | 209.3 | 172.5 | 118 | 98.1 |
Net Income to Company | 241.3 | 220.7 | 209.3 | 172.5 | 118 | 98.1 |
Minority Interest in Earnings | -0.7 | -0.9 | -1.9 | -0.3 | -0.4 | -1.6 |
Net Income | 240.6 | 219.8 | 207.4 | 172.2 | 117.6 | 96.5 |
Net Income to Common | 240.6 | 219.8 | 207.4 | 172.2 | 117.6 | 96.5 |
Net Income Growth | 21.15% | 5.98% | 20.44% | 46.43% | 21.87% | 58.46% |
Shares Outstanding (Basic) | 15 | 15 | 15 | 15 | 15 | 15 |
Shares Outstanding (Diluted) | 15 | 15 | 15 | 15 | 15 | 15 |
Shares Change | 0.47% | 0.94% | 0.05% | 0.33% | 0.04% | 3.10% |
EPS (Basic) | 16.07 | 14.67 | 14.00 | 11.63 | 7.94 | 6.52 |
EPS (Diluted) | 16.07 | 14.67 | 14.00 | 11.60 | 7.90 | 6.50 |
EPS Growth | 20.81% | 4.80% | 20.66% | 46.84% | 21.54% | 53.18% |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 363.4 | 317 | 318.2 | 205.9 | 59.2 | 71 |
Free Cash Flow Per Share | 24.26 | 21.13 | 21.41 | 13.86 | 4.00 | 4.80 |
Gross Margin | 59.38% | 58.67% | 58.52% | 58.42% | 60.25% | 61.38% |
Operating Margin | 14.05% | 13.69% | 13.32% | 13.61% | 13.26% | 11.21% |
Profit Margin | 10.66% | 10.42% | 11.48% | 10.84% | 10.46% | 10.42% |
Free Cash Flow Margin | 16.10% | 15.03% | 17.61% | 12.96% | 5.27% | 7.66% |
EBITDA | 428.9 | 377.2 | 304.8 | 268.3 | 188.6 | 141.1 |
EBITDA Margin | 19.00% | 17.88% | 16.86% | 16.89% | 16.78% | 15.23% |
D&A For EBITDA | 111.7 | 88.5 | 64 | 52.1 | 39.5 | 37.3 |
EBIT | 317.2 | 288.7 | 240.8 | 216.2 | 149.1 | 103.8 |
EBIT Margin | 14.05% | 13.69% | 13.32% | 13.61% | 13.26% | 11.21% |
Effective Tax Rate | 23.10% | 23.63% | 19.99% | 22.40% | 22.37% | 16.15% |
Revenue as Reported | 161.5 | - | - | - | - | - |